selected publications
-
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2016
Academic Article
GET IT
Times cited: 184 -
Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges.
Immunotherapy.
2016
Review
GET IT
Times cited: 118 -
Ipilimumab in patients with melanoma and autoimmune disease.
Journal for immunotherapy of cancer.
2014
Academic Article
GET IT
Times cited: 87 -
Opportunistic infections in patients treated with immunotherapy for cancer.
Journal for immunotherapy of cancer.
2014
Academic Article
GET IT
Times cited: 1263 -
A case report of trastuzumab dose in gastric cancer.
2013
GET IT
Times cited: 7 -
Checkpoint blocking antibodies in cancer immunotherapy.
FEBS letters.
2013
Review
GET IT
Times cited: 210 -
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
2013
GET IT
Times cited: 89